Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 2c6e | HPM | Aurora kinase A | 2.7.11.1 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 2c6e | HPM | Aurora kinase A | 2.7.11.1 | 1.000 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.496 | |
| 1ad5 | ANP | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.494 | |
| 4c3p | ACP | Aurora kinase A | 2.7.11.1 | 0.489 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.481 | |
| 4o0u | ADN | Aurora kinase A | 2.7.11.1 | 0.474 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.467 | |
| 2wqe | ADP | Aurora kinase A | 2.7.11.1 | 0.464 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.461 | |
| 3ztx | ZTX | Aurora kinase B-A | 2.7.11.1 | 0.456 | |
| 3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.452 | |
| 3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.450 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.446 | |
| 5l8l | ADP | Aurora kinase A | 2.7.11.1 | 0.446 | |
| 4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.442 | |
| 2vrx | 447 | Aurora kinase B-A | 2.7.11.1 | 0.441 | |
| 4jbp | YPH | Aurora kinase A | 2.7.11.1 | 0.441 | |
| 3q4z | ANP | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.440 | |
| 4eym | 0RX | Mitogen-activated protein kinase 13 | 2.7.11.24 | 0.440 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.440 |